Clinical Trials Logo

Clinical Trial Summary

Pneumococcal polysaccharide vaccine does not confer protection against noninvasive pneumonia. The study aims to compare lymphocyte homing in pneumonia and in those receiving Pnc polysaccharide vaccine (PPV) or Pnc conjugate vaccine (PCV)


Clinical Trial Description

Pneumococcal polysaccharide vaccine does not confer protection against noninvasive pneumonia. The study compares the homing profiles of Pnc-specific plasmablasts in 15 patients with pneumonia and in 15 volunteers receiving Pnc polysaccharide vaccine (PPV) and 12 volunteers receiving Pnc conjugate vaccine (PCV) ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01402245
Study type Interventional
Source Helsinki University Central Hospital
Contact
Status Completed
Phase Phase 4
Start date January 2005
Completion date June 2010

See also
  Status Clinical Trial Phase
Completed NCT03303976 - Phase I to Test a New Pneumococcal Vaccine Phase 1
Completed NCT02592486 - The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine Phase 4
Completed NCT03851978 - Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain N/A
Completed NCT01444352 - Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults Phase 1
Completed NCT03619252 - Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents Phase 4
Active, not recruiting NCT01028326 - PCV10 Reactogenicity and Immunogenicity Study - Malindi Phase 4
Completed NCT01444339 - Study of Two Investigational Pneumococcal Vaccines in Healthy Adults Phase 1
Completed NCT01444001 - Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers Phase 1